Summary: New research indicates Parkinson’s disease can develop silently for more than a decade before motor symptoms appear. The study shows that neural circuits controlling movement remain functional even after a dramatic reduction in activity-dependent dopamine release—challenging common assumptions about the immediate role of dopamine loss in producing motor deficits.
Dopamine is widely recognized as essential for coordinating movement, and its decline is a defining feature of Parkinson’s disease. These findings offer fresh insight into why symptoms emerge late in the disease course and point toward new therapeutic strategies to manage or delay motor impairment.
Key Facts:
- The study suggests Parkinson’s disease may progress silently for over ten years before clinical symptoms become apparent.
- Movement-related brain circuits showed surprising resilience, maintaining normal motor behavior despite near-abolition of activity-driven dopamine secretion.
- Understanding the mechanisms that preserve basal dopamine signaling could open new avenues to treat or reduce Parkinson’s symptoms.
Source: University of Montreal
Have you or someone close to you recently received a Parkinson’s diagnosis? New evidence indicates the disease may have been quietly advancing for more than a decade prior to symptom onset.
Researchers at the Université de Montréal reported these findings in Nature Communications, revealing unexpected resilience in the brain’s motor system during the asymptomatic phase of Parkinson’s disease.
Led by neuroscientist Louis-Éric Trudeau, the team used genetic tools to prevent dopamine-producing neurons from releasing dopamine in response to normal electrical signals. This manipulation targeted the activity-dependent secretion of dopamine while leaving other cellular functions intact.
Because dopamine is a central chemical messenger for movement and coordination, the researchers initially expected the mice to display motor deficits similar to those seen in Parkinson’s patients. Benoît Delignat-Lavaud, a doctoral student in Trudeau’s lab, anticipated clear movement impairments when activity-dependent dopamine release was removed.
To their surprise, the genetically modified mice performed normally on a range of unconditioned motor tasks. They even succeeded in a task measuring conditioned motivation for food—behaviors commonly thought to rely on phasic, activity-driven dopamine signaling.
Measuring dopamine levels
At the same time, measurements of extracellular dopamine in the striatum—performed by Louis de Beaumont’s team at the Centre de recherche de l’Hôpital du Sacré-Cœur de Montréal—showed that basal dopamine concentrations remained stable. In other words, while rapid, activity-dependent dopamine release was nearly abolished, the steady background level of dopamine in the brain persisted.
These findings suggest that many basic motor behaviors rely primarily on a tonic, basal level of dopamine rather than phasic bursts tied to neuronal firing. As a result, the early stages of Parkinson’s disease may not produce visible motor problems because baseline dopamine remains sufficient despite a progressive loss of dopamine-producing neurons.
Motor symptoms likely appear only after dopamine innervation falls below a critical threshold. This helps explain the long silent progression of Parkinson’s disease and why substantial neuronal loss is typically observed by the time clinical motor signs emerge.
By clarifying which types of dopamine release are essential for maintaining movement, the study points researchers toward molecular and cellular targets that preserve basal dopamine tone. Identifying these mechanisms could lead to novel treatments designed to prolong functional dopamine signaling and delay or reduce motor symptoms in Parkinson’s patients.
About this Parkinson’s disease research news
Author: Jeff Heinrich
Source: University of Montreal
Contact: Jeff Heinrich – University of Montreal
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice” by Louis-Éric Trudeau et al. Nature Communications
Abstract
Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice
In Parkinson’s disease (PD), motor dysfunction typically becomes evident only after a substantial loss of dopamine (DA) innervation. This resilience has been attributed to the capacity of motor systems to function on a diffuse basal tone of DA; however, direct experimental evidence has been limited.
The authors show that conditional deletion of the calcium sensor synaptotagmin-1 (Syt1) in DA neurons (Syt1 cKODA mice) largely abolishes activity-dependent axonal DA release in the striatum and midbrain, while preserving somatodendritic DA release. Remarkably, Syt1 cKODA mice maintained normal performance across multiple unconditioned DA-dependent motor tasks and in a task assessing conditioned motivation for food.
Given that basal extracellular DA levels in the striatum remained unchanged, the findings indicate that phasic, activity-dependent DA release is not required for these basic motor behaviors, which can be sustained by a tonic extracellular DA tone. Overall, the results reveal a striking robustness of DA-dependent motor functions despite near-complete loss of phasic DA release and shed light on why extensive DA innervation loss is necessary before motor impairments emerge in PD.